Digital Secondary Prevention in Cardiovascular Disease
PreventiPlaque - Digital Secondary Prevention in Cardiovascular Disease to Improve Therapy Adherence
Sponsor: University Hospital, Essen
This NA trial investigates Atherosclerotic Plaque and is currently ongoing. University Hospital, Essen leads this study, which shows 4 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Nov 2023 — Jul 2024 [monthly]
Unknown Status NA
Status: Not Yet Recruiting → Unknown Status
-
Nov 2021 — Nov 2023 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Essen
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.